Sometimes it feel like we're invested in a call option rather that a stock - delays mean an erosion of the time value but as many have mentioned what we have is delays not denials from the FDA - my theory is that we're going to need a few positive events in a row to get the shareprice moving - a nice article for Rex-L regarding CHF in the NEJM would be a fine start and from there some positive news from OTAT re CQA and a confirmation of the Novartis deal following shortly thereafter and we'll have the ball rolling again.
Great Company, Great Future!, page-65
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.045(4.52%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 94.5¢ | $2.669M | 2.769M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2053 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 13191 | 2 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |